A
UL icon

Astrantus’s Unilever UL Stock Holding History

Astrantus’s Portfolio UL Stock Details UL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$474K Buy
+9,244
New +$515K 0.8% 9

Other funds holding UL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
GRQ
Gardner Russo & Quinn Lancaster, Pennsylvania $8.93B AUM 6.76% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return
GQG Partners
GQG Partners Ft. Lauderdale, Florida $53.8B AUM 19.23% 1-Year Est. Return
FMI
Fiduciary Management Inc Milwaukee, Wisconsin $7.03B AUM 11.68% 1-Year Est. Return
PG
Pendal Group Sydney, Australia $11.6B AUM 12.87% 1-Year Est. Return

Astrantus's UL Position: Q1 2022 in Review

Astrantus opened a new position in Unilever (UL) in Q1 2022: 9,244 shares worth $474K. The stake represents 0.8% of the portfolio and ranks #9 among its holdings.

1,021 funds tracked by Wall St. Rank hold UL as of Q1 2022.

  • Astrantus held 9,244 shares of Unilever worth $474K as of Q1 2022.
  • Unilever was a new Astrantus position in Q1 2022.
  • Unilever made up 0.8% of Astrantus's portfolio in Q1 2022, its #9 holding.
  • 1,021 funds tracked by Wall St. Rank held Unilever as of Q1 2022.

Based on Astrantus's 13F filing for Q1 2022, filed 11 May 2022.